S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
S&P 500   4,455.48 (+0.15%)
DOW   34,798.00 (+0.10%)
QQQ   373.33 (+0.09%)
AAPL   146.92 (+0.06%)
MSFT   299.35 (-0.07%)
FB   352.96 (+2.02%)
GOOGL   2,844.30 (+0.71%)
TSLA   774.39 (+2.75%)
AMZN   3,425.52 (+0.28%)
NVDA   220.81 (-1.78%)
BABA   145.08 (-4.04%)
NIO   35.38 (-1.75%)
CGC   13.91 (-4.46%)
GE   103.80 (+0.82%)
MU   74.05 (+0.01%)
AMD   105.80 (-0.33%)
T   27.13 (-0.22%)
F   13.78 (+0.51%)
ACB   5.95 (-3.25%)
DIS   176.00 (-0.14%)
PFE   43.94 (-0.57%)
BA   221.39 (+0.13%)
AMC   40.01 (+0.08%)
NASDAQ:BNFT

Benefitfocus Stock Forecast, Price & News

$11.32
-0.04 (-0.35 %)
(As of 09/24/2021 04:00 PM ET)
Add
Compare
Today's Range
$11.20
$11.48
50-Day Range
$10.94
$13.32
52-Week Range
$9.42
$17.58
Volume84,150 shs
Average Volume310,752 shs
Market Capitalization$377.48 million
P/E RatioN/A
Dividend YieldN/A
Beta1.71
30 days | 90 days | 365 days | Advanced Chart
Receive BNFT News and Ratings via Email

Sign-up to receive the latest news and ratings for Benefitfocus and its competitors with MarketBeat's FREE daily newsletter.


Benefitfocus logo

About Benefitfocus

Benefitfocus, Inc. engages in the provision of cloud-based benefits management platform for consumers, employers, insurance carriers, and brokers. The company was founded by Mason R. Holland and Shawn A. Jenkins in June 2000 and is headquartered in Charleston, SC.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

2.09 out of 5 stars

Computer And Technology Sector

357th out of 858 stocks

Prepackaged Software Industry

98th out of 251 stocks

Analyst Opinion: 2.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 4.2Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Benefitfocus (NASDAQ:BNFT) Frequently Asked Questions

Is Benefitfocus a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Benefitfocus in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Benefitfocus stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BNFT, but not buy additional shares or sell existing shares.
View analyst ratings for Benefitfocus
or view top-rated stocks.

What stocks does MarketBeat like better than Benefitfocus?

Wall Street analysts have given Benefitfocus a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Benefitfocus wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Benefitfocus?

Benefitfocus saw a drop in short interest in August. As of August 13th, there was short interest totaling 1,460,000 shares, a drop of 38.9% from the July 29th total of 2,390,000 shares. Based on an average daily trading volume, of 345,500 shares, the short-interest ratio is presently 4.2 days. Approximately 5.0% of the company's shares are short sold.
View Benefitfocus' Short Interest
.

When is Benefitfocus' next earnings date?

Benefitfocus is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Benefitfocus
.

How were Benefitfocus' earnings last quarter?

Benefitfocus, Inc. (NASDAQ:BNFT) released its earnings results on Monday, August, 2nd. The software maker reported ($0.18) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.13) by $0.05.
View Benefitfocus' earnings history
.

How has Benefitfocus' stock been impacted by Coronavirus?

Benefitfocus' stock was trading at $10.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BNFT shares have increased by 10.9% and is now trading at $11.32.
View which stocks have been most impacted by COVID-19
.

What guidance has Benefitfocus issued on next quarter's earnings?

Benefitfocus issued an update on its third quarter 2021 earnings guidance on Tuesday, August, 10th. The company provided earnings per share (EPS) guidance of $-0.310-$-0.240 for the period, compared to the Thomson Reuters consensus estimate of $-0.120. The company issued revenue guidance of $58 million-$60 million, compared to the consensus revenue estimate of $59.64 million.

What price target have analysts set for BNFT?

4 equities research analysts have issued 1-year target prices for Benefitfocus' stock. Their forecasts range from $12.00 to $17.00. On average, they anticipate Benefitfocus' share price to reach $14.00 in the next twelve months. This suggests a possible upside of 23.7% from the stock's current price.
View analysts' price targets for Benefitfocus
or view top-rated stocks among Wall Street analysts.

Who are Benefitfocus' key executives?

Benefitfocus' management team includes the following people:
  • Matthew C. Levin, President, Chief Executive Officer & Director
  • Ken Haderer, Executive Vice President-Global Operations
  • Alpana Wegner, Chief Financial Officer (LinkedIn Profile)
  • Ravi Metta, Executive Vice President-Product & Engineering
  • Sean Wechter, Chief Information Officer

What is Steve Swad's approval rating as Benefitfocus' CEO?

9 employees have rated Benefitfocus CEO Steve Swad on Glassdoor.com. Steve Swad has an approval rating of 60% among Benefitfocus' employees. This puts Steve Swad in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Benefitfocus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Benefitfocus investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Designer Brands (DBI), STMicroelectronics (STM), Athabasca Oil (ATH) and Honeywell International (HON).

What is Benefitfocus' stock symbol?

Benefitfocus trades on the NASDAQ under the ticker symbol "BNFT."

Who are Benefitfocus' major shareholders?

Benefitfocus' stock is owned by many different retail and institutional investors. Top institutional investors include Archon Capital Management LLC (6.90%), BlackRock Inc. (6.88%), Vanguard Group Inc. (5.24%), ArrowMark Colorado Holdings LLC (4.46%), Ancient Art L.P. (2.80%) and Deutsche Bank AG (2.26%). Company insiders that own Benefitfocus stock include Alpana Wegner, Annmarie Fini and James P Restivo.
View institutional ownership trends for Benefitfocus
.

Which institutional investors are selling Benefitfocus stock?

BNFT stock was sold by a variety of institutional investors in the last quarter, including Jefferies Group LLC, Jefferies Group LLC, Vanguard Group Inc., ArrowMark Colorado Holdings LLC, BlackRock Inc., Bluefin Capital Management LLC, Bluefin Capital Management LLC, and Northern Trust Corp.
View insider buying and selling activity for Benefitfocus
or view top insider-selling stocks.

Which institutional investors are buying Benefitfocus stock?

BNFT stock was bought by a variety of institutional investors in the last quarter, including Archon Capital Management LLC, Deutsche Bank AG, Renaissance Technologies LLC, Point72 Asset Management L.P., Parametric Portfolio Associates LLC, Bank of Montreal Can, SG Americas Securities LLC, and Simplex Trading LLC.
View insider buying and selling activity for Benefitfocus
or or view top insider-buying stocks.

How do I buy shares of Benefitfocus?

Shares of BNFT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Benefitfocus' stock price today?

One share of BNFT stock can currently be purchased for approximately $11.32.

How much money does Benefitfocus make?

Benefitfocus has a market capitalization of $377.48 million and generates $268.14 million in revenue each year. The software maker earns $-24,300,000.00 in net income (profit) each year or ($0.77) on an earnings per share basis.

How many employees does Benefitfocus have?

Benefitfocus employs 1,200 workers across the globe.

What is Benefitfocus' official website?

The official website for Benefitfocus is www.benefitfocus.com.

Where are Benefitfocus' headquarters?

Benefitfocus is headquartered at 100 BENEFITFOCUS WAY, CHARLESTON SC, 29492.

How can I contact Benefitfocus?

Benefitfocus' mailing address is 100 BENEFITFOCUS WAY, CHARLESTON SC, 29492. The software maker can be reached via phone at (843) 849-7476 or via email at [email protected].


This page was last updated on 9/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.